Tag: Competition

Displaying 1441 - 1460 of 2148 results.

Pages

Following a public comment period, the Commission has approved a final consent order in the matter of BASF and Ciba Specialty Chemicals. The vote approving the final order was 4-0. (FTC File No. 081-0265; the staff contact is Wallace W. Easterling, Bureau of Competition, 202-326-2936; see press...
Federal Trade Commission staff have filed a comment stating that the amended version of proposed Louisiana House Bill 687, if enacted, would further restrict competition to provide dental care to underserved children in the state, without providing any countervailing benefits to consumers. The...
The Federal Trade Commission has formally dismissed the complaint in the Rambus matter. “While we remain disappointed by the decision of the Court of Appeals, we of course respect the Court’s opinion and will move forward,” said Richard A. Feinstein, Director of the Bureau of Competition. “The...
Federal Trade Commission Chairman Jon Leibowitz announced today that Ken Glazer, Senior Deputy Director of the Bureau of Competition, plans to leave the FTC this month. “Ken is a first-rate lawyer and antitrust thinker,” said Chairman Leibowitz. “We are grateful for his service to the public, his...
The Federal Trade Commission today issued a Revised Notice of Proposed Rulemaking (RNPRM) seeking public comment on a revised proposed rule that would prohibit market manipulation in the petroleum industry. The revised proposed rule would prohibit anyone from engaging in fraud or deceit in...
The Federal Trade Commission’s Bureau of Competition has advised TriState Health Partners, Inc. (TriState), a physician-hospital organization based in Hagerstown, Maryland, that staff has no present intention to recommend that the Commission challenge the organization’s proposed clinical...
Following a public comment period, the Commission has approved a final consent order in the matter of National Association of Music Merchants, Inc. (NAMM). The vote approving the final order was 4-0. (FTC File No. 001-0203; the staff contact is William Lanning, Bureau of Competition, 202-326-3361...
The Federal Trade Commission today announced the fifth and final hearing in a series exploring the evolving market for intellectual property. This hearing will be held May 4-5, 2009, on the campus of the University of California at Berkeley, in cooperation with the Berkeley Center for Law and...
The Federal Trade Commission has brought to a halt two peddlers of bogus cancer cures that were targeted during Operation False Cures, a law enforcement sweep announced last fall. The FTC charged the companies in the sweep with making unsupported claims that their concoctions treated, cured, or...
BASF has settled Commission charges that its proposed $5.1 billion acquisition of rival chemical manufacturer Ciba Holding Inc. would be anticompetitive and violate federal law by reducing competition in the worldwide markets for two high performance pigments. Under the terms of a...
BASF has settled Federal Trade Commission charges that its proposed $5.1 billion acquisition of rival chemical manufacturer Ciba Holding Inc. would be anticompetitive and violate federal law by reducing competition in the worldwide markets for two high performance pigments. Under the terms of a...
Federal Trade Commission Chairman Jon Leibowitz announced today that David P. Wales, Acting Director of the Bureau of Competition for the past nine months, will leave the FTC in May. “Dave has done a terrific job in leading the Bureau of Competition during an active period of antitrust enforcement...
Drug maker Bristol-Myers Squibb Company (BMS) will pay $2.1 million – the largest fine allowed by law – for failing to inform the Federal Trade Commission of agreements reached with Apotex, Inc., regarding potential generic competition to its blockbuster drug Plavix. BMS’s conduct violated a 2003...
Testifying today on behalf of the Federal Trade Commission before the U.S. House Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, FTC Commissioner J. Thomas Rosch said that anticompetitive patent settlements in the U.S. pharmaceutical industry “...
Drug maker Bristol-Myers Squibb Company (BMS) agreed to pay $2.1 million – the largest fine allowed by law – for failing to inform the FTC of agreements reached with Apotex, Inc., regarding potential generic competition to its blockbuster drug Plavix. BMS’s conduct violated a 2003...
According to the staff of the Federal Trade Commission, legislation pending before the Minnesota legislature that seeks to exempt certain activities by Minnesota health care cooperatives from federal and state antitrust law likely would raise health care costs and reduce insurance coverage for...
The Federal Trade Commission today announced the fourth in a series of public hearings exploring the evolving market for intellectual property. These hearings, to be held April 17, 2009, in Washington, DC, will explore how corporations, inventors, and patent intermediaries value and monetize...
– Following a public comment period, the Commission has approved a final consent order in the matter of Getinge AB and Datascope Corp. The vote approving the final order was 3-0, with Commissioner Pamela Jones Harbour recused. (FTC File No. 091-0000; the staff contact is David L. Inglefield,...

Pages